Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WANBURY vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WANBURY   MYLAN
EQUITY SHARE DATA
    WANBURY
Mar-23
MYLAN
Dec-18
WANBURY/
MYLAN
5-Yr Chart
Click to enlarge
High Rs903,969-   
Low Rs332,185-   
Sales per share (Unadj.) Rs152.81,826.3-  
Earnings per share (Unadj.) Rs-3.249.6-  
Cash flow per share (Unadj.) Rs0.6391.5-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-10.51,975.7-  
Shares outstanding (eoy) m32.71514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.41.7 23.8%   
Avg P/E ratio x-19.362.0 -31.1%  
P/CF ratio (eoy) x100.87.9 1,282.4%  
Price / Book Value ratio x-5.81.6 -373.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,0041,582,973 0.1%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m8100-   
Avg. sales/employee Rs Th026,846.0-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0729.0-  
INCOME DATA
Net Sales Rs m4,996939,609 0.5%  
Other income Rs m100-   
Total revenues Rs m5,007939,609 0.5%   
Gross profit Rs m225243,136 0.1%  
Depreciation Rs m124175,932 0.1%   
Interest Rs m21445,192 0.5%   
Profit before tax Rs m-10322,012 -0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1-3,502 -0.0%   
Profit after tax Rs m-10425,514 -0.4%  
Gross profit margin %4.525.9 17.4%  
Effective tax rate %-1.1-15.9 6.7%   
Net profit margin %-2.12.7 -76.6%  
BALANCE SHEET DATA
Current assets Rs m1,222524,677 0.2%   
Current liabilities Rs m3,204382,547 0.8%   
Net working cap to sales %-39.715.1 -262.3%  
Current ratio x0.41.4 27.8%  
Inventory Days Days484 4.8%  
Debtors Days Days49793 532.2%  
Net fixed assets Rs m1,742182,269 1.0%   
Share capital Rs m327500 65.4%   
"Free" reserves Rs m-6720-   
Net worth Rs m-3441,016,486 -0.0%   
Long term debt Rs m01,097,114 0.0%   
Total assets Rs m2,9842,726,609 0.1%  
Interest coverage x0.51.5 34.9%   
Debt to equity ratio x01.1 -0.0%  
Sales to assets ratio x1.70.3 485.9%   
Return on assets %3.72.6 142.1%  
Return on equity %30.22.5 1,202.3%  
Return on capital %-32.23.2 -1,014.1%  
Exports to sales %58.00-   
Imports to sales %20.50-   
Net fx Rs m1,9250-   
CASH FLOW
From Operations Rs m198195,251 0.1%  
From Investments Rs m-88-100,923 0.1%  
From Financial Activity Rs m-320-90,959 0.4%  
Net Cashflow Rs m-2101,618 -13.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.38 Rs / USD

Compare WANBURY With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare WANBURY With: KIMIA BIOSCIENCES  EARUM PHARMACEUTICALS  AVON ORGANIC  HINDUSTAN BIOSCIE  NECTAR LIFESCIENCE  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.